Patent · US Active

Method of treating dyslipidemic disorder

US7994120B2 · kind B2 · utility

8Cited by
8References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2007
Grant dateAug 9, 2011
Priority date
Expiry dateJul 4, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P9/12
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides methods of treating or preventing a condition or disorder associated with dyslipidemia with compositions comprising apolipoprotein-sphingomyelin complexes. The methods of the invention permit reduction, by 4- to 20-fold, of the amount of apolipoprotein required for therapeutic administration to bring about an ameliorative effect.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.